Laura Koth, MD
Laura Koth received a B.S. degree from the University of California, Los Angeles in Biochemistry and an M.D. degree from Harvard Medical School in 1994. She completed her Internal Residency training at Massachusetts General Hospital in Boston, Massachusetts and her Pulmonary/Critical Care fellowship at the University of California, San Francisco. She joined the UCSF Pulmonary faculty in 2003.
Her research activities focus on the immunologic mechanisms of lung inflammation and macrophage activation. Her clinical interest is Granulomatous Interstitial Lung Diseases and she is the Director of the Granulomatous Interstitial Lung Disease Research Program at UCSF. Dr. Koth started the Sarcoidosis Research Program in 2010, and oversees a longitudinal cohort of patients with sarcoidosis and unaffected volunteers.
Dr. Koth is the Principal Investigator of the West Coast site of the NIH-funded GRADS (GENOMIC RESEARCH IN ALPHA 1 ANTITRYPSIN DEFICIENCY AND SARCOIDOSIS) study which should begin enrollment in 2013 and its goal is to study the role of infection in sarcoidosis and A1AT. If you wish to learn more or participate, please contact us at 415-476-5896. You can also visit our web site at http://sarcoidosis.ucsf.edu.
Lee JH, Kaminski N, Dolganov G, Grunig G, Koth L, Solomon C, Erle DJ, Sheppard D. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol. 2001 Oct; 25(4):474-85.
UCSF Profile Page: http://profiles.ucsf.edu/laura.koth
UCSF Pulmonary Website: http://pulmonary.ucsf.edu/about/faculty.html?key=f9fa6738c29679a2c81016c...